| Identification of differentially expressed miRNA in the rat hippocampus during adolescence through an epigenome-wide analysis. A Vázquez-Ágredos, P Rovira, B Gutiérrez, F Gámiz, M Gallo Developmental Neuroscience, 2024 | | 2024 |
| Influence of BDNF Val66Met genetic polymorphism in Major Depressive Disorder and Body Mass Index: Evidence from a meta-analysis of 6481 individuals AM Pérez-Gutiérrez, P Rovira, B Gutiérrez, JA Cervilla, JA Zarza-Rebollo, ... Journal of Affective Disorders 344, 458-465, 2024 | 1 | 2024 |
| Schizophrenia polygenic risk score in psychosis proneness P Mas-Bermejo, S Papiol, M Via, P Rovira, P Torrecilla, TR Kwapil, ... European Archives of Psychiatry and Clinical Neuroscience 273 (8), 1665-1675, 2023 | 3 | 2023 |
| EXPLORING THE MODULATING ROLE OF BDNF VAL66MET POLYMORPHISM ON THE IMPACT OF PHYSICAL ACTIVITY IN COGNITIVE PERFORMANCE IN A LARGE ANDALUSIAN COMMUNITY SAMPLE P Rovira, M Rivera, E Molina, J Cervilla, B Gutiérrez IBRO Neuroscience Reports 15, S888-S889, 2023 | | 2023 |
| Mendelian randomization analysis for attention deficit/hyperactivity disorder: studying a broad range of exposures and outcomes M Soler Artigas, C Sánchez-Mora, P Rovira, L Vilar-Ribó, ... International journal of epidemiology 52 (2), 386-402, 2023 | 17 | 2023 |
| Exploring the role of BDNF Val66Met polymorphism on the impact of physical activity in cognitive performance in a community sample P Rovira, M Rivera, E Molina, JA Cervilla, B Gutiérrez Neuroscience Applied 2, 103627, 2023 | | 2023 |
| Toxoplasma gondii Seropositivity Interacts with Catechol-O-methyltransferase Val105/158Met Variation Increasing the Risk of Schizophrenia P Rovira, B Gutiérrez, A Sorlózano-Puerto, J Gutiérrez-Fernández, ... Genes 13 (6), 1088, 2022 | 5 | 2022 |
| Toxoplasma gondii Infection Interacts with Catechol-O-methyltransferase Val158Met Genotype Increasing the Risk of Schizophrenia. P Rovira, B Gutiérrez, A Sorlózano-Puerto, J Gutiérrez-Fernández, ... Genes, 2022, vol. 13, num. 6, 2022 | | 2022 |
| TH4. A CAUSAL ROLE FOR ATTENTION DEFICIT/HYPERACTIVITY DISORDER ON RISK-TAKING BEHAVIOURS, ACADEMIC AND FINANCIAL PROBLEMS AND MAJOR DEPRESSION MS Artigas, C Sánchez-Mora, P Rovira, L Vilar-Ribó, JA Ramos-Quiroga, ... European Neuropsychopharmacology 51, e195-e196, 2021 | | 2021 |
| A CAUSAL ROLE FOR ATTENTION DEFICIT/HYPERACTIVITY DISORDER ON RISK-TAKING BEHAVIOURS, ACADEMIC AND FINANCIAL PROBLEMS AND MAJOR DEPRESSION M Soler Artigas, C Sanchez-Mora, P Rovira, L Vilar-Ribo, ... EUROPEAN NEUROPSYCHOPHARMACOLOGY 51, E195-E196, 2021 | | 2021 |
| Genetic association study of childhood aggression across raters, instruments, and age HF Ip, CM Van der Laan, EML Krapohl, I Brikell, C Sánchez-Mora, ... Translational psychiatry 11 (1), 413, 2021 | 68 | 2021 |
| " Attention-deficit/hyperactivity disorder and lifetime cannabis use: Genetic overlap and causality": Correction. MS Artigas, C Sánchez-Mora, P Rovira, V Richarte, I Garcia-Martínez, ... Nature Publishing Group, 2021 | | 2021 |
| Correction to: Attention-deficit/hyperactivity disorder and lifetime cannabis use: genetic overlap and causality M Soler Artigas, C Sánchez-Mora, P Rovira, V Richarte, I Garcia-Martínez, ... Molecular psychiatry 26 (7), 3663-3663, 2021 | 3 | 2021 |
| Structural brain imaging studies offer clues about the effects of the shared genetic etiology among neuropsychiatric disorders NV Radonjić, JL Hess, P Rovira, O Andreassen, JK Buitelaar, CRK Ching, ... Molecular psychiatry 26 (6), 2101-2110, 2021 | 77 | 2021 |
| Meta-analysis and systematic review of ADGRL3 (LPHN3) polymorphisms in ADHD susceptibility EM Bruxel, CR Moreira-Maia, GC Akutagava-Martins, TP Quinn, M Klein, ... Molecular psychiatry 26 (6), 2277-2285, 2021 | 26 | 2021 |
| Genetic overlap and causality between substance use disorder and attention‐deficit and hyperactivity disorder L Vilar‐Ribó, C Sánchez‐Mora, P Rovira, V Richarte, M Corrales, ... American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 186 …, 2021 | 37 | 2021 |
| Transcriptome profiling in adult attention-deficit hyperactivity disorder N Mortimer, C Sanchez-Mora, P Rovira, L Vilar-Ribo, V Richarte, ... European Neuropsychopharmacology 41, 160-166, 2020 | 12 | 2020 |
| Attention-deficit/hyperactivity disorder and lifetime cannabis use: genetic overlap and causality M Soler Artigas, C Sánchez-Mora, P Rovira, V Richarte, I Garcia-Martínez, ... Molecular Psychiatry 25 (10), 2493-2503, 2020 | 75 | 2020 |
| Shared genetic background between children and adults with attention deficit/hyperactivity disorder P Rovira, D Demontis, C Sánchez-Mora, T Zayats, M Klein, NR Mota, ... Neuropsychopharmacology 45 (10), 1617-1626, 2020 | 107 | 2020 |
| Epigenome-wide association study of attention-deficit/hyperactivity disorder in adults P Rovira, C Sánchez-Mora, M Pagerols, V Richarte, M Corrales, ... Translational psychiatry 10 (1), 199, 2020 | 22 | 2020 |
